Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
EPERISONE HYDROCHLORIDE
DKSH MALAYSIA SDN BHD
EPERISONE HYDROCHLORIDE
100Tablet Tablets
Bushu Pharmaceuticals Ltd. Misato factory
MYONAL ® 50MG TABLET Eperisone hydrochloride (50mg) 1 _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ WHAT IS IN THIS LEAFLET 1. What Myonal is used for 2. How Myonal works 3. Before you use Myonal 4. How to use Myonal 5. While you are using it 6. Side effects 7. Storage and Disposal of Myonal 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT MYONAL IS USED FOR Myonal is intended for: a) Improvement of myotonic conditions (prolonged contraction of muscles) caused by the following diseases: Neck-shoulder-arm syndrome Frozen shoulder Low back pain b) Condition of muscles in a state of continuous contraction, causing dysfunction in muscle movement and increased tendon reflexes. This is caused by the following diseases: Brain blood vessel disorders Arthritis of the neck Surgical trauma from brain and spine tumor Spinal and head injury Brain disorder that affects the ability to coordinate body movements Degeneration of spinal cord and brain Other diseases that affect both the brain and the spinal cord HOW MYONAL WORKS Myonal acts by relaxing both skeletal muscles and vascular smooth muscles. These reduce muscular spasm and improve blood circulation. Meanwhile, Myonal reduces pain associated with myotonic condition while facilitates muscle movement. BEFORE YOU USE _MYONAL_ - _When you must not use it _ Do not take Myonal if you have a history of hypersensitivity to any ingredients of Myonal. _ _ _ _ _Pregnancy and lactation _ Do not take Myonal if you are pregnant, trying to get pregnant or think you may be pregnant unless the expected therapeutic benefits are evaluated to outweigh the possible risk of treatment. Do not take Myonal if you are breast- feeding. When Myonal must be used, breast feeding should be discontinued during treatment. Myonal _ _ is not recommended for children. _ _ - _Before you start use it _ Consult your doctor before using _Myonal_ if you have A history of drug hypersensitivity Hepatic function dis Read the complete document
CAUTION: USE ONLY AS DIRECTED BY A PHYSICIAN. 【COMPOSITION】 - For improvement of myotonic symptoms - _MYONAL_ ® 50 mg _TABLETS _2. USE DURING LACTATION It is advisable to avoid the administration of MYONAL to nursing mothers. 【PHARMACOKINETICS】 BLOOD CONCENTRATION Eperisone hydrochloride was administered orally to 8 healthy adult male volunteers at a single dose of 150 mg/day note ) for 14 consecutive days and the plasma concentration was determined at days 1, 8 and 14. The time to reach the peak plasma concentration (t max ) ranged from 1.6 to 1.9 hr, the peak plasma concentration (c max ) was 7.5 to 7.9 ng/mL, elimination half-life (t 1/2 ) was 1.6 to 1.8 hr, and the area under the plasma concentration- time curve (AUC) was 19.7 to 21.1 ng ・ hr/mL. The plasma concentration profiles of eperisone hydrochloride determined at days 8 and 14 did not significantly vary from those of the first day. 【EXCIPIENTS】 It contains carnauba wax, carmellose, micro crystalline cellulose, titanium oxide, stearic acid, calcium stearate, sucrose, talc, precipitated calcium carbonate, corn starch, white shellac, hydroxypropylcellulose, pullulan, povidone K30, macrogol 6000 and hydrated silicon dioxide as inactive ingredients. 【EXPIRATION DATE】 MYONAL should be used before the expiration date indicated on the package or label. 【STORAGE】 MYONAL should be stored below 30°C. Each white, sugar-coated tablet contains 50 mg of eperisone hydrochloride. 【PRODUCT DESCRIPTION】 【INDICA TIONS】 ・ Improvement of myotonic conditions caused by the following diseases: Neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain ・ Spastic paralysis caused by the following diseases : Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, sequelae of surgical trauma (including cerebrospinal tumor), sequelae of trauma (spinal injury and head injury), amyotrophic lateral sclerosis, infantile cerebral palsy, spinocerebellar degeneration, spinal vascu Read the complete document